Cargando…
Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression
INTRODUCTION: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons as well as the presence of proteinaceous inclusions named Lewy bodies. α-synuclein (α-syn) is a major constituent of Lewy bodies, and the first disease-causing protein...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513748/ https://www.ncbi.nlm.nih.gov/pubmed/26205255 http://dx.doi.org/10.1186/s40478-015-0222-2 |
_version_ | 1782382686164221952 |
---|---|
author | Bourdenx, Mathieu Dovero, Sandra Engeln, Michel Bido, Simone Bastide, Matthieu F. Dutheil, Nathalie Vollenweider, Isabel Baud, Laetitia Piron, Camille Grouthier, Virginie Boraud, Thomas Porras, Grégory Li, Qin Baekelandt, Veerle Scheller, Dieter Michel, Anne Fernagut, Pierre-Olivier Georges, François Courtine, Grégoire Bezard, Erwan Dehay, Benjamin |
author_facet | Bourdenx, Mathieu Dovero, Sandra Engeln, Michel Bido, Simone Bastide, Matthieu F. Dutheil, Nathalie Vollenweider, Isabel Baud, Laetitia Piron, Camille Grouthier, Virginie Boraud, Thomas Porras, Grégory Li, Qin Baekelandt, Veerle Scheller, Dieter Michel, Anne Fernagut, Pierre-Olivier Georges, François Courtine, Grégoire Bezard, Erwan Dehay, Benjamin |
author_sort | Bourdenx, Mathieu |
collection | PubMed |
description | INTRODUCTION: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons as well as the presence of proteinaceous inclusions named Lewy bodies. α-synuclein (α-syn) is a major constituent of Lewy bodies, and the first disease-causing protein characterized in PD. Several α-syn-based animal models of PD have been developed to investigate the pathophysiology of PD, but none of them recapitulate the full picture of the disease. Ageing is the most compelling and major risk factor for developing PD but its impact on α-syn toxicity remains however unexplored. In this study, we developed and exploited a recombinant adeno-associated viral (AAV) vector of serotype 9 overexpressing mutated α-syn to elucidate the influence of ageing on the dynamics of PD-related neurodegeneration associated with α-syn pathology in different mammalian species. RESULTS: Identical AAV pseudotype 2/9 vectors carrying the DNA for human mutant p.A53T α-syn were injected into the substantia nigra to induce neurodegeneration and synucleinopathy in mice, rats and monkeys. Rats were used first to validate the ability of this serotype to replicate α-syn pathology and second to investigate the relationship between the kinetics of α-syn-induced nigrostriatal degeneration and the progressive onset of motor dysfunctions, strikingly reminiscent of the impairments observed in PD patients. In mice, AAV2/9-hα-syn injection into the substantia nigra was associated with accumulation of α-syn and phosphorylated hα-syn, regardless of mouse strain. However, phenotypic mutants with either accelerated senescence or resistance to senescence did not display differential susceptibility to hα-syn overexpression. Of note, p-α-syn levels correlated with nigrostriatal degeneration in mice. In monkeys, hα-syn-induced degeneration of the nigrostriatal pathway was not affected by the age of the animals. Unlike mice, monkeys did not exhibit correlations between levels of phosphorylated α-syn and neurodegeneration. CONCLUSIONS: In conclusion, AAV2/9-mediated hα-syn induces robust nigrostriatal neurodegeneration in mice, rats and monkeys, allowing translational comparisons among species. Ageing, however, neither exacerbated nigrostriatal neurodegeneration nor α-syn pathology per se. Our unprecedented multi-species investigation thus favours the multiple-hit hypothesis for PD wherein ageing would merely be an aggravating, additive, factor superimposed upon an independent disease process. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0222-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4513748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45137482015-07-25 Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression Bourdenx, Mathieu Dovero, Sandra Engeln, Michel Bido, Simone Bastide, Matthieu F. Dutheil, Nathalie Vollenweider, Isabel Baud, Laetitia Piron, Camille Grouthier, Virginie Boraud, Thomas Porras, Grégory Li, Qin Baekelandt, Veerle Scheller, Dieter Michel, Anne Fernagut, Pierre-Olivier Georges, François Courtine, Grégoire Bezard, Erwan Dehay, Benjamin Acta Neuropathol Commun Research INTRODUCTION: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons as well as the presence of proteinaceous inclusions named Lewy bodies. α-synuclein (α-syn) is a major constituent of Lewy bodies, and the first disease-causing protein characterized in PD. Several α-syn-based animal models of PD have been developed to investigate the pathophysiology of PD, but none of them recapitulate the full picture of the disease. Ageing is the most compelling and major risk factor for developing PD but its impact on α-syn toxicity remains however unexplored. In this study, we developed and exploited a recombinant adeno-associated viral (AAV) vector of serotype 9 overexpressing mutated α-syn to elucidate the influence of ageing on the dynamics of PD-related neurodegeneration associated with α-syn pathology in different mammalian species. RESULTS: Identical AAV pseudotype 2/9 vectors carrying the DNA for human mutant p.A53T α-syn were injected into the substantia nigra to induce neurodegeneration and synucleinopathy in mice, rats and monkeys. Rats were used first to validate the ability of this serotype to replicate α-syn pathology and second to investigate the relationship between the kinetics of α-syn-induced nigrostriatal degeneration and the progressive onset of motor dysfunctions, strikingly reminiscent of the impairments observed in PD patients. In mice, AAV2/9-hα-syn injection into the substantia nigra was associated with accumulation of α-syn and phosphorylated hα-syn, regardless of mouse strain. However, phenotypic mutants with either accelerated senescence or resistance to senescence did not display differential susceptibility to hα-syn overexpression. Of note, p-α-syn levels correlated with nigrostriatal degeneration in mice. In monkeys, hα-syn-induced degeneration of the nigrostriatal pathway was not affected by the age of the animals. Unlike mice, monkeys did not exhibit correlations between levels of phosphorylated α-syn and neurodegeneration. CONCLUSIONS: In conclusion, AAV2/9-mediated hα-syn induces robust nigrostriatal neurodegeneration in mice, rats and monkeys, allowing translational comparisons among species. Ageing, however, neither exacerbated nigrostriatal neurodegeneration nor α-syn pathology per se. Our unprecedented multi-species investigation thus favours the multiple-hit hypothesis for PD wherein ageing would merely be an aggravating, additive, factor superimposed upon an independent disease process. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0222-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-25 /pmc/articles/PMC4513748/ /pubmed/26205255 http://dx.doi.org/10.1186/s40478-015-0222-2 Text en © Bourdenx et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Bourdenx, Mathieu Dovero, Sandra Engeln, Michel Bido, Simone Bastide, Matthieu F. Dutheil, Nathalie Vollenweider, Isabel Baud, Laetitia Piron, Camille Grouthier, Virginie Boraud, Thomas Porras, Grégory Li, Qin Baekelandt, Veerle Scheller, Dieter Michel, Anne Fernagut, Pierre-Olivier Georges, François Courtine, Grégoire Bezard, Erwan Dehay, Benjamin Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression |
title | Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression |
title_full | Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression |
title_fullStr | Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression |
title_full_unstemmed | Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression |
title_short | Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression |
title_sort | lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513748/ https://www.ncbi.nlm.nih.gov/pubmed/26205255 http://dx.doi.org/10.1186/s40478-015-0222-2 |
work_keys_str_mv | AT bourdenxmathieu lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT doverosandra lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT engelnmichel lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT bidosimone lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT bastidematthieuf lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT dutheilnathalie lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT vollenweiderisabel lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT baudlaetitia lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT pironcamille lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT grouthiervirginie lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT boraudthomas lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT porrasgregory lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT liqin lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT baekelandtveerle lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT schellerdieter lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT michelanne lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT fernagutpierreolivier lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT georgesfrancois lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT courtinegregoire lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT bezarderwan lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression AT dehaybenjamin lackofadditiveroleofageinginnigrostriatalneurodegenerationtriggeredbyasynucleinoverexpression |